Paul F. Lizzul's Net Worth
$26.4 Thousand
Who is Paul F. Lizzul?
Paul F. Lizzul does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ANAPTYSBIO, INC, and Sienna Biopharmaceuticals, Inc..
SEC CIK
Paul F. Lizzul's CIK is 0001711462
Past Insider Trading and Trends
2019 was Paul F. Lizzul's most active year for acquiring shares with 10 total transactions. Paul F. Lizzul's most active month to acquire stocks was the month of July. 2019 was Paul F. Lizzul's most active year for disposing of shares, totalling 6 transactions. Paul F. Lizzul's most active month to dispose stocks was the month of July. 2017 saw Paul F. Lizzul paying a total of $150,000.00 for 32,483 shares, this is the most they've acquired in one year. In 2023 Paul F. Lizzul cashed out on 8,105 shares for a total of $41,005.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ANAPTYSBIO, INC (ANAB) Snapshot price: $23.515
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$26.75 | -$24,750.00 | 11.62K |
Scheduled
|
Jul 18
| ||
Form 4
| +55.02% | 3.59K |
$21.81 | -$55,702.74 | 10.12K |
Jan 6 - Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +147.99% | 3.9K |
$19.48 | -$41,005.40 | 6.53K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
∞
| 964 |
$22.03 | $21,236.92 | 964 |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sienna Biopharmaceuticals, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +38.87% | 55K |
—
|
—
| 196.49K |
Aug 6
| |||
Form 4
| -2.81% | -4.09K |
$0.76 | -$3,112.20 | 141.49K |
Jul 2
| |||
Form 4
| +46.11% | 45K |
—
|
—
| 142.58K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +24.29% | 20.56K |
$15.00 | $150,000.00 | 105.19K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||